Picture of Cencora logo

COR Cencora Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Cencora, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2021
September 30th
2022
September 30th
2023
September 30th
2024
September 30th
2025
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue213,989238,587262,173293,959321,333
Cost of Revenue
Gross Profit6,7748,3358,8079,79311,292
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses211,635236,176259,792291,783318,704
Operating Profit2,3542,4112,3812,1752,629
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes2,2222,1832,1612,0042,258
Provision for Income Taxes
Net Income After Taxes1,5451,6671,7331,5191,568
Minority Interest
Net Income Before Extraordinary Items
Net Income1,5401,6991,7451,5091,554
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income1,5401,6991,7451,5091,554
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS8.469.429.1310.811.9
Dividends per Share